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Oocytes are formed in utero; menopause occurs when the oocyte pool is depleted. The authors hypothesized
that early-life events could affect the number of a woman’s oocytes and determine age at menopause. To test their
hypothesis, the authors conducted a secondary analysis of baseline data from 22,165 participants in the Sister
Study (2003–2007) who were aged 35–59 years at enrollment. To estimate the association between early-life
events and age at natural menopause, the authors used Cox proportional hazards models to estimate hazard ratios
with 95% confidence intervals, adjusting for current age, race/ethnicity, education, childhood family income, and
smoking history. Earlier menopause was associated with in-utero diethylstilbestrol exposure (hazard ratio (HR) ¼
1.45, 95% confidence interval (CI): 1.27, 1.65). Suggestive associations included maternal prepregnancy diabetes
(HR ¼ 1.33, 95% CI: 0.89, 1.98) and low birth weight (HR ¼ 1.09, 95% CI: 0.99, 1.20). Having a mother aged 35
years or older at birth appeared to be associated with a later age at menopause (HR ¼ 0.95, 95% CI: 0.89, 1.01).
Birth order, in-utero smoke exposure, and having been breastfed were not related to age at menopause. In-utero
and perinatal events may subsequently influence age at menopause.
diethylstilbestrol; menopause; pregnancy; prenatal exposure delayed effects; risk factors
Abbreviations: CI, confidence interval; DES, diethylstilbestrol; HR, hazard ratio; SD, standard deviation.
Menopause is not only a transition from the reproductive
years to reproductive senescence but also a health transition.
Following menopause, hormonal and metabolic changes oc-
cur, leading to an increase in risk for cardiovascular disease
(1) and fractures (2). Age at menopause appears to be directly
correlated with age at onset of perimenopausal menstrual
cycle irregularity (3) and onset of age-related infertility.
Therefore, factors that influence age at menopause may affect
not only timing of cessation of menses but also future car-
diovascular and reproductive health.
Reproductive aging, the natural progression of the repro-
ductive system through stages of fertility, subfertility, peri-
menopause, and finally menopause, progresses with the
decline in the number of oocytes (4). Age at menopause is
thought to reflect the size of the initial cohort of follicles and
the rate of oocyte loss (5). If this is so, factors that affect the
pace of oocyte atresia or the initial size of the cohort of
follicles may change age at menopause. The number of
oocytes peaks at approximately 5 million around 24 weeks’
gestation (6) but then declines steadily to around 2 million at
birth (7). The high rate of loss continues in the prepubertal
years, such that only 300,000 oocytes remain at puberty (8),
at which time the rate of loss slows.
Adulthood exposures may affect age at menopause by
accelerating the pace of oocyte atresia. Previous studies
have shown that adult environmental exposures such as
smoking (9), exposure to toxicants such as chemotherapeu-
tic agents (10), and possibly body mass index (11) and al-
cohol (12) appear to affect age at menopause. Other factors
affecting the timing of menopause include race/ethnicity
(13) and mother’s age at menopause (14), which may be
due to shared genetic or environmental factors. A twin study
that revealed 63% heritability for age at menopause supports
the role of genetic factors in age at menopause (15). How-
ever, twins also share a common in-utero environment;
therefore, these similarities may be due in part to events
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occurring during pregnancy, birth, or childhood. Specifi-
cally, perinatal and in-utero exposures which influence the
size of the initial oocyte cohort and early rates of loss could
affect age at menopause. Our objective in this study was to
explore the impact of early-life events (prenatal, birth, and
neonatal) on age at natural menopause.
MATERIALS AND METHODS
This study was an analysis of baseline data obtained for
the Sister Study (www.SisterStudy.org), a prospective co-
hort study of US and Puerto Rican women aged 35–74 years
who were enrolled between August 2003 and March 2009.
The Sister Study was designed to assess genetic and envi-
ronmental risk factors for breast cancer and other condi-
tions. Women without breast cancer who had a full or
half-sister with a history of breast cancer were eligible for
the study. Through a computer-assisted telephone interview,
investigators collected information on menstrual and gyne-
cologic history, socioeconomic characteristics, smoking his-
tory, and reproductive history, among other factors.
Participants also completed a self-administered question-
naire on early-life events and exposures. A prepaid tele-
phone card was provided to participants to encourage
them to contact relatives for information.
Data were available for 32,071 women who completed
their baseline home visit and interview by September 21,
2007. We excluded women who underwent natural meno-
pause prior to age 30 years (n ¼ 32), since these cases were
most likely due to sex chromosome aneuploidy (16); women
who underwent menarche after age 18 years (n ¼ 27); and
women who had never had menses (n ¼ 4). We further re-
stricted our analysis to 22,209 participants who were under
age 60 years at the time of interview to minimize secular and
recall differences within the cohort. The current analysis
included 22,165 women after exclusion of 44 women who
were missing data on age at menopause.
Menopausal status
Age at natural menopause was the primary outcome for
this analysis. Women were considered menopausal if they
answered ‘‘No’’ to the question, ‘‘Have you had a menstrual
period in the past 12 months?’’ (We did not count women
who had had no menses because of pregnancy or breastfeed-
ing or because of premenopausal use of medications which
induce amenorrhea.) Age at menopause was defined by the
answer to the question, ‘‘How old were you when you had
your last menstrual period?’’ Women who had undergone
a hysterectomy, bilateral oophorectomy, uterine artery em-
bolization, endometrial ablation, or chemotherapy that had
stopped their periods prior to spontaneous menopause were
censored at the time of their surgically or medically induced
amenorrhea. Premenopausal women were censored at their
age at interview.
Exposure and covariate assessment
We used self-administered questionnaires to assess intra-
uterine and early-life exposures. Participant characteristics
included birth weight (pounds/ounces), timing of birth rel-
ative to due date, birth order, birth interval, singleton or
multiple birth, consumption of breast milk or soy formula
during infancy, and childhood food shortages. Characteris-
tics of the participant’s mother at the time of the pregnancy
and the participant’s birth included maternal age at delivery,
prepregnancy diabetes, gestational diabetes, gestational hy-
pertension, preeclampsia or eclampsia, morning sickness,
maternal farm exposure, diethylstilbestrol (DES) intake,
smoking, and seizure disorder. Paternal characteristics in-
cluded age at the participant’s birth and periconceptional
smoking. We only analyzed paternal and household in-utero
smoking exposure when the mother was a nonsmoker during
pregnancy.
Maternal and paternal characteristics (except for age at
participant’s birth) and consumption of breast milk and soy
formula included the following response categories: ‘‘defi-
nitely,’’ ‘‘probably,’’ ‘‘probably not,’’ ‘‘definitely not,’’ and
‘‘don’t know.’’ For analyses, responses were collapsed into 2
categories: exposed, including the responses ‘‘definitely’’
and ‘‘probably,’’ and unexposed, including the responses
‘‘probably not’’ and ‘‘definitely not.’’ ‘‘Don’t know’’ re-
sponses were coded as missing data.
For analyses, maternal diabetes was separated into 3
mutually exclusive categories: no diabetes, diabetes pre-
ceding pregnancy, and diabetes during pregnancy only. The
gestational diabetes group excluded mothers with prepreg-
nancy diabetes but included mothers whose prepregnancy
diabetes status was unknown. Maternal hypertension was
divided into 3 mutually exclusive categories: no hyperten-
sion, isolated hypertension in pregnancy, and preeclampsia
or eclampsia in pregnancy. The isolated hypertension
group excluded mothers with preeclampsia or eclampsia
but included mothers whose preeclampsia or eclampsia
status was unknown. Information on maternal hyperten-
sion was considered missing if the participant responded
negatively regarding 1 form of hypertension (either iso-
lated or preeclampsia/eclampsia) and ‘‘unknown’’ regard-
ing another. Maternal farm exposure was divided into 4
mutually exclusive categories: 1) mother lived and worked
on a farm during pregnancy, 2) mother lived on a farm but
did not work on a farm, 3) mother worked on a farm but did
not live on a farm, and 4) mother did not live or work on
a farm.
Birth order and birth interval (for nonfirstborn persons;
number of years between index birth and preceding sibling’s
birth) was estimated from the birth dates of brothers re-
ported in self-administered family history questionnaires
and sisters reported during computer-assisted telephone in-
terviews. For these definitions, we considered only siblings
(full and half) who shared the same mother. Only nonfirst-
born persons were included in birth interval analyses.
Additional covariates on which data were collected dur-
ing the telephone interview included self-reported category
of childhood family income, participant’s age, highest level
of education, race/ethnicity, and smoking status between
ages 40 and 49 years (or current smoking status for women
who were under age 40 years at the time of interview).
Because of a substantial proportion of missing responses,
we did not assess associations with gestational age at
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delivery (43% missing) and maternal morning sickness
(29% missing).
Statistical analyses
All statistical analyses were conducted using STATA 10.0
(Stata Corporation, College Station, Texas). Initially, bivar-
iate analyses were conducted using only the subset of
the cohort that underwent natural menopause, to determine
the most appropriate method for modeling continuous and
categorical exposures. Subsequently, we created multiple
Kaplan-Meier curves to graphically assess violation of
the proportional hazards assumption. It was noted that the
curves became unstable after age 56 years; thus, participants
were censored at 56 years of age, assuring that the propor-
tional hazards assumption was met with all variables.
We used multiple Cox proportional hazards models to
estimate hazard ratios with 95% confidence intervals for
the associations between each of the intrauterine or early-
life exposures and age at natural menopause. Exposures
with hazard ratios greater than 1 were associated with earlier
onset of menopause, and those with hazard ratios less than 1
were associated with later age at menopause.
Each model contained a set of core covariates—factors
that might affect reporting, risk factors that might affect the
precision of the estimates, or risk factors previously shown
to be strongly associated with age at menopause: participant
age, participant race/ethnicity (white, black, Hispanic, or
other), participant’s highest level of education, childhood
family income, and participant’s smoking status in her
40s. In 893 (4%) observations, at least 1 core variable was
missing a value. To improve power, we imputed these core
variable values using STATA’s ice command, which imputes
missing values by using switching regression, an iterative
multivariable regression technique.
The majority of participants were missing responses for
at least 1 early-life exposure. Some exposures (e.g., low
birth weight) may be considered potential intermediates
on the causal pathway between another early-life exposure
(e.g., hypertension in pregnancy) and age at menopause.
Therefore, we created multiple Cox proportional hazards
models, each including the core covariates and 1 intrauter-
ine or early-life exposure of interest. In post hoc analyses to
address potential confounding within pairs of exposures that
appeared important, we used pairwise models or excluded
specific exposed groups.
RESULTS
Of the 22,165 women included in the analysis, 6,659
(30%) had undergone natural menopause, 10,161 (46%)
were still menstruating, and the remaining 5,345 (24%)
had undergone surgical or medically induced menopause.
Average age at the last menstrual period for those women
who had experienced natural menopause was 49.3 years
(standard deviation (SD), 4.2) (median, 50 years), while
average age at the last menstrual period for those who were
still menstruating was 45.8 years (SD, 5.0), and for those
who had undergone medical or surgically induced meno-
pause, it was 40.3 years (SD, 7.3). Median age at menopause
for the entire cohort, based on survival analysis, was 52
years. A full description of the analyzed cohort is provided
in Table 1 and Table 2. Participants in this analysis tended to
be white and educated.
Only 1 perinatal exposure, definite or probable in-utero
exposure to DES, was found to be significantly associated
with age at menopause. Time to age at menopause in the
exposed and unexposed groups is presented graphically in
Figure 1A. Women exposed to DES in utero underwent
menopause at 1.45 times (95% confidence interval (CI):
1.27, 1.65) the rate of women who were not exposed. This
resulted in an unadjusted median age at menopause of 51
years (interquartile range, 49–54) for those exposed and 52
years (interquartile range, 50–55) for those unexposed. DES
exposure was subsequently expanded into 3 categories of
exposure: definite, probable, and unexposed. A stronger as-
sociation was observed in women responding ‘‘definite’’
DES exposure (n ¼ 440; hazard ratio (HR) ¼ 1.61, 95%
CI: 1.37, 1.88) than in women responding ‘‘probable’’ ex-
posure (n ¼ 269; HR ¼ 1.23, 95% CI: 0.98, 1.54). Hazard
ratios were unchanged when women whose mothers had
diabetes were excluded.
Other early-life exposures that tended to be associated
with age at menopause included maternal diabetes and ma-
ternal age at birth, birth weight, singleton or multiple birth,
and birth interval (Table 2). Women whose mothers had
prepregnancy diabetes (HR ¼ 1.33, 95% CI: 0.89, 1.98) or
gestational diabetes (HR ¼ 1.16, 95% CI: 0.79, 1.69) re-
ported menopause earlier than women whose mothers did
not have diabetes (Figure 1B). Hazard ratios were un-
changed when mother’s age at delivery was included in
the model. In a subgroup analysis excluding women who
were exposed to DES in utero, the associations were not as
strong for prepregnancy diabetes (HR¼ 1.22, 95% CI: 0.80,
1.88) and gestational diabetes (HR ¼ 1.09, 95% CI: 0.73,
1.65).
Women who reported low birth weight (<2,500 g) un-
derwent menopause earlier (HR¼ 1.09, 95% CI: 0.99, 1.20;
Figure 2), but macrosomia (birth weight >4,000 g) did not
appear to delay age at menopause. The strength of this as-
sociation was not substantially altered when women whose
mothers had diabetes or women who were DES-exposed or
part of a multiple gestation were excluded from the analysis.
Women who were part of a multiple gestation reported men-
opause earlier than their singleton counterparts (HR ¼ 1.10,
95% CI: 0.96, 1.25). Multiple gestation without low birth
weight was not associated with earlier menopause in com-
parison with all singletons (HR¼ 1.01, 95% CI: 0.85, 1.21),
but multiple gestation with low birth weight did appear to be
associated with earlier menopause (HR ¼ 1.20, 95% CI:
0.99, 1.47).
Older maternal age at birth (35 years) was associated
with later age at menopause (compared with mothers aged
20–34 years, HR ¼ 0.95, 95% CI: 0.89, 1.01). The strength
of this association was not altered when women whose
mothers had diabetes or women who had been exposed to
DES in utero were excluded from the analysis. While birth
order was not associated with age at menopause, a long
birth interval (6 years) preceding the participant’s birth
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appeared to be associated with a delay in the onset of
menopause (compared with a birth interval of 2–5 years,
HR ¼ 0.94, 95% CI: 0.86, 1.02). Being breastfed was not
associated with age at menopause (HR ¼ 1.01, 95% CI:
0.96, 1.06). Separate analyses with imputed and nonimputed
data resulted in nearly identical estimates (data not shown).
In a sensitivity analysis, women who were coded as being
naturally menopausal were excluded from analysis if they
had used hormone replacement therapy more than 1 year
prior to their stated age at menopause (n ¼ 703) or if they
were taking hormonal birth control at menopause (n¼ 457).
Women who were considered to be premenopausal were
excluded from the analysis if they were currently on hor-
mone replacement therapy (n¼ 340). The remaining 20,665
observations were included in the sensitivity analysis. The
exclusion of these women did not appreciatively alter the
findings.
Unadjusted analyses showed a potential relation between
childhood food shortages and earlier menopause (HR ¼
1.09, 95% CI: 0.99, 1.19). However, after adjustment for
adult factors (age at interview, race/ethnicity, education,
and smoking status), the association was attenuated
(HR ¼ 1.04, 95% CI: 0.95, 1.14). Further adjustment for
childhood family income did not significantly alter the
association (HR ¼ 1.05, 95% CI: 0.95, 1.16).
DISCUSSION
Oocyte numbers peak prior to birth, and oocyte depletion
continues throughout life. Once the number of oocytes de-
clines to approximately 1,000, menopause occurs (17). We
hypothesized that perinatal events would affect the size of
the initial cohort and subsequent age at menopause. We
found that in-utero DES exposure was associated with an
earlier age at menopause. Maternal diabetes and low birth
weight appeared to be associated with an earlier age at
menopause, but estimates were imprecise. Maternal age at
delivery over 34 years and birth interval over 5 years tended
to be associated with a delayed age at menopause.
Table 1. Core Covariates Included in All Models and Their Associations With Age at









Age, years 50.06 (6.08) 1.04 1.03, 1.05
Race/ethnicity
White 20,083 91 1 Referent
Black 972 4 1.07 0.93, 1.23
Hispanic 524 2 1.12 0.93, 1.34
Other 585 3 1.08 0.92, 1.26
Missing data 1
Education
High school or less 2,638 12 1.15 1.06, 1.26
Some college or an
associate’s degree
7,087 32 1.02 0.96, 1.09
Bachelor’s degree 6,728 30 1 Referent
Master’s or doctoral
degree




Smoker 3,560 17 1.40 1.31, 1.49
Nonsmoker 17,730 83 1 Referent
Missing data 875
Childhood family income
Well-off 1,579 7 0.98 0.89, 1.08
Middle-income 14,464 65 1 Referent
Low-income 4,949 22 0.98 0.93, 1.04
Poor 1,154 5 0.99 0.89, 1.11
Missing data 19
Abbreviation: SD, standard deviation.
a Each hazard ratio was adjusted for all of the other core covariates.
b Or current smoking, if under age 40 years.
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Table 2. Adjusted Hazard Ratios for Associations of Intrauterine and Early-Life ExposuresWith









Mean maternal age at birth
(n ¼ 21,711), years
28.9 (6.0) 0.996 0.99, 1.00
Maternal age at birth, years
<20 840 4 0.999 0.87, 1.14
20–34 16,687 77 1 Referent




Yes 101 <1 0.78 0.48, 1.25




Hypertension only 345 2 1.01 0.82, 1.24
Preeclampsia or eclampsia 431 2 1.02 0.85, 1.21
No 18,667 96 1 Referent
Missing data 2,722
Maternal diabetes
Preceding pregnancy 81 <1 1.33 0.89, 1.98
Gestational diabetes only 119 <1 1.16 0.79, 1.69
None 19,992 99 1 Referent
Missing data 1,973
Maternal farm exposure
Lived on farm 919 4 0.99 0.88, 1.11
Worked on farm 244 1 0.92 0.73, 1.17
Lived and worked on farm 1,872 9 1.00 0.92, 1.10




Yes 709 4 1.45 1.27, 1.65




Yes 7,503 36 1.02 0.97, 1.07
No 13,626 64 1 Referent
Missing data 1,036
Paternal smokingb
(if mother was a
nonsmoker; n ¼ 14,662)
Yes 7,791 57 1.01 0.94, 1.07
No 5,857 43 1 Referent
Missing data 1,014
Table continues
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(if mother was a
nonsmoker; n ¼ 14,662)
Yes 6,746 49 1.03 0.96, 1.09
No 6,941 51 1 Referent
Missing data 975
Mean paternal age at birth
(n ¼ 21,659), years
31.9 (6.9) 0.997 0.99, 1.00
Birth order
Firstborn or only child 4,207 19 1.01 0.95, 1.07
Not firstborn 17,613 81 1 Referent
Missing data 345
Mean birth interval, years
(n ¼ 17,562)
3.40 (2.56) 0.99 0.98, 1.00
Birth interval, years
(n ¼ 17,562)
1 3,284 19 1.03 0.96, 1.11
2–5 11,565 66 1 Referent
6 2,713 15 0.94 0.86, 1.02
Birth weight, g
<2,500 1,476 8 1.09 0.99, 1.20
2,500–4,000 14,516 84 1 Referent
>4,000 1,319 8 1.03 0.92, 1.14
Missing data 4,854
Multiple gestation
Yes 764 3 1.10 0.96, 1.25
No 21,103 97 1 Referent
Missing data 298
Breastfed
Yes 8,275 40 1.01 0.96, 1.06
No 12,473 60 1 Referent
Missing data 1,417
Soy-fed
Yes 713 4 0.97 0.82, 1.14
No 17,885 96 1 Referent
Missing data 3,567
Soy-fed in first 2 months of life
Yes 421 2 0.95 0.76, 1.18
No 18,125 98 1 Referent
Missing data 3,619
Childhood food shortage
Yes 1,768 8 1.05 0.95, 1.16
No 20,386 92 1 Referent
Missing data 11
Abbreviation: SD, standard deviation.
a In each model, results were adjusted for participant’s age, race/ethnicity, educational level,
smoking status in the participant’s 40s, and childhood family income.
b Exposure to paternal smoking around the time of conception.
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Earlier menopause with in-utero DES exposure was also
found in the National Cancer Institute DES cohort (18), with
similar hazard ratios (our HR ¼ 1.45; National Cancer In-
stitute HR ¼ 1.49). In our study, women exposed to DES in
utero went through menopause approximately 1 year earlier
than women who were not exposed to DES. A previous
case-control study of women in their late 30s did not find
a higher prevalence of menopausal women in the group
exposed to DES in utero (19). Therefore, DES does not
appear to be a significant cause of premature ovarian failure
(menopause prior to age 40 years).
DES may lead to earlier menopause by causing abnormal
uterine development, affecting the initial oocyte pool, or
changing atresia rates. DES is known to cross the placenta.
During fetal development, it may disrupt hormonal signal-
ing and lead to altered transcription of genes important for
the differentiation of the female reproductive tract (20). The
shape of the uterus can be altered, leading to an increase in
the risk of cervical incompetence and preterm delivery. Ev-
idence in rodents suggests that the number of oocytes or the
rate of atresia is altered. Rats exposed to DES in utero have
fewer primordial follicles 3 weeks after birth (21); fewer ova
are retrieved following ovulation induction from DES-
exposed mice than from nonexposed mice (22).
Earlier menopause among women born to mothers with
diabetes compared with women whose mothers were not
diabetic is also biologically plausible. Vascular compromise
could lead to intrauterine growth restriction and poor ovar-
ian development. Glucose could be toxic to developing oo-
cytes. In addition, genetic factors might explain a link. Type
1 diabetes is associated with certain human leukocyte anti-
gen polymorphisms that have been found in women with
premature ovarian failure (23, 24). Both mother and daugh-
ter may share genetic susceptibility factors for familial au-
toimmune polyglandular failure that could result in both
diabetes and premature ovarian failure (25).
In this study, low birth weight was weakly associated with
earlier menopause (HR ¼ 1.09, 95% CI: 0.99, 1.20). To our
knowledge, this is the first study to show this association.
The work of de Bruin et al. (26), showing a smaller volume
percentage of primordial follicles in growth-restricted hu-
man fetal ovaries as compared with age-matched controls,
gives the finding biologic plausibility. While some investi-
gators have not found an association between birth weight
and age at menopause (27–31), shortness at birth and a high
ponderal index (birth weight/length3) were associated with
earlier menopause in 1 study (27). Poor infant weight gain
(up to age 2 years) also has been reported to lead to earlier
age at menopause (27, 29, 31). Perhaps it is the process
leading to poor weight gain (in or out of the uterus) rather
than weight per se that may lead to earlier menopause.
We failed to find an association between being breastfed
and age at menopause. Two previous analyses of a British
birth cohort (Medical Research Council National Survey of
Health and Development) found that being breastfed was
associated with later menopause (29, 31), and the effect
was stronger for women who were breastfed for more than
6 months. For the British cohort, breastfeeding information
was obtained from the mother when her daughter was 2 years
of age, while our study relied on daughters’ self-reports and
did not use data on duration, because many women could not
report it. A biologic mechanism by which breastfeeding may
delay oocyte depletion has not been proposed.
Figure 2. Prevalence of women who were still menstruating, by birth
weight (solid line, normal birth weight (2,500 g); dashed line, low
birth weight (<2,500 g)), Sister Study, 2003–2007.
Figure 1. Prevalence of women who were still menstruating as
a function of age, by A) level of exposure to diethylstilbestrol (DES)
in utero (solid line, unexposed; dashed line, exposed) and B) expo-
sure to maternal diabetes (solid line, unexposed; dashed line, partic-
ipant’s mother had diabetes prior to pregnancy; dotted line,
participant’s mother had diabetes during pregnancy only), Sister
Study, 2003–2007.
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We did not find an association between in-utero exposure
to cigarette smoking and age at menopause. Strohsnitter
et al. (32) reported that women exposed to cigarette smoke
in utero were more likely to be postmenopausal (HR¼ 1.21,
95% CI: 1.20, 1.43). The relation was present only among
women who were not current smokers. After restricting
analyses to women who did not smoke in their 40s, we still
did not find an association with in-utero smoke exposure
(HR ¼ 1.04, 95% CI: 0.98, 1.11). While in-utero exposure
to cigarette smoke may be harmful to developing oocytes,
genetic factors and other adult exposures may play a more
dominant role in determining age at menopause.
In this study, there initially appeared to be an association
between childhood food shortages and earlier menopause;
however, after adjustment for adult socioeconomic factors
and smoking status, the association was attenuated. No as-
sociation between childhood household income and age at
menopause was noted. Multiple studies have indicated that
there may be an association between low childhood socio-
economic status and earlier menopause. Researchers have
specifically examined father’s social class (29, 31), house-
hold crowding (29, 31), household number of bathrooms
(30), sharing a bedroom (30), and access to a car (30). Some
of the associations persisted after adjustment for adult fac-
tors (30), while other studies showed attenuated associations
(29, 31).
In our study, older maternal age at birth and longer birth
interval were weakly associated with later age at meno-
pause, and these factors were themselves correlated. Any
association between having been born to a woman aged
35 years or older may simply reflect shared genetic factors
affecting fertile life span (highly correlated with age of
menopause), as has been suggested by heritability of ovarian
reserves (33) and the significant correlation between
mothers’ and daughters’ ages at menopause (34).
This study was limited by its use of retrospectively col-
lected data on early-life factors that may not have been
well reported. To minimize reporting errors, participants
were provided with a prepaid telephone card and encour-
aged to consult their mother or other family members.
Exposures with a high proportion of missing data, such
as estimated gestational age at delivery, duration of breast-
feeding, and maternal nausea and vomiting during preg-
nancy, could not be analyzed. We restricted the analysis to
women aged 35–59 years to minimize cohort effects, out-
come information bias, and possible exposure misclassifi-
cation. Previous research indicates that, in general, women
can provide valid estimates of their age at menopause (33,
34). To our knowledge, this is the largest study to have
examined the impact of early-life events on age at meno-
pause. Cox proportional hazards models were used to eval-
uate associations with time to menopause while adjusting
for adult smoking, a strong predictor of age at menopause,
and factors that might have affected reporting accuracy,
like education. Cause of menopause was determined for
each individual, and women with surgical or medical men-
opause were censored.
Participants in the Sister Study are sisters of women with
breast cancer. Use of this cohort may enrich the prevalence
of exposures related to breast cancer risk (due to sharing of
genetics and environment with sisters), but the magnitude
and direction of associations with the outcome studied
should not differ. Any bias introduced by having studied
sisters of women with breast cancer would probably be
small (35).
In conclusion, early-life events may influence future age
at menopause. Early menopause among daughters exposed
to DES in utero was confirmed, and there was suggestive
evidence for low birth weight and maternal diabetes.
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